{"schema_version":"secwatch.filing_event.v1","accession":"0001472375-25-000083","form_type":"8-K","ticker":"RGPX","cik":"0001357878","company_name":"REGENEREX PHARMA, INC.","filed_at":"2025-07-31T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.810027+00:00","generated_at":"2026-05-17T22:13:42.069680+00:00","sec_items":["1.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Regenerex Pharma enters licensing deal with Holista for ovine collagen wound care","bullets":["Exclusive rights to use Holista's ovine collagen in wound care and distribution in USA.","Ovine nano-collagen integrated into Regenerex's QBx™ technology to accelerate deep tissue regeneration.","Collagen sourced from ethically raised, disease-free Australian sheep; avoids mad cow disease concerns.","CEO Greg Pilant says ovine collagen is safer and more culturally acceptable than bovine/porcine sources.","Agreement targets advanced wound care solutions for U.S. and international markets."],"urls":{"canonical":"https://secwatch.observer/filing/0001472375-25-000083","json":"https://secwatch.observer/filing/0001472375-25-000083.json","markdown":"https://secwatch.observer/filing/0001472375-25-000083.md","text":"https://secwatch.observer/filing/0001472375-25-000083.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357878/000147237525000083/0001472375-25-000083-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357878/000147237525000083/ixform8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T22:13:42.069680+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}